Abstract:
PROBLEM TO BE SOLVED: To provide a benzenesulfonic acid salt of (S)-4-[4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]butanoic acid having excellent antihistaminic activities and antiallergic activities, and to provide a process for producing the salt. SOLUTION: The process for producing the optically active substance compound represented by formula (IV) includes deriving (±)-4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidine into a diastereomer salt, and optically resolving the resultant diastereomer salt by a method for fractional crystallization. COPYRIGHT: (C)2011,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To obtain the subject new compound excellent in antihistaminic activity and antiallergic activity, having a few hygroscopic property, excellent in physicochemical property and useful as a medicine. SOLUTION: This new compound is benzenesulfonic acid salt of a compound represented by formula I. The new compound is preferably obtained by subjecting 1 mol compound of formula I to salt formation reaction with 0.9-1.2 mol benzenesulfonic acid in a solvent such as ethyl acetate, preferably at 10-35 deg.C. The solvent is preferably used in an amount of 1 to 10 L based on 1 mol compound of formula I. The temperature at salt deposition is preferably -10 to 15 deg.C. The compound of formula I is obtained by reacting an optically active (S)-4-[(4-chlorophenyl) (2-pyridyl)methoxy]piperidin with a compound of formula II (W is an eleiminable group; R is a lower alkyl) (e.g. ethyl 4- bromobutanoate) in an inert solvent in the presence of a base and then subjecting the resultant compound of formula III to hydrolysis reaction.
Abstract:
PROBLEM TO BE SOLVED: To obtain a medicine useful for a prophylactic or therapeutic agent of embolism, thrombosis or arteriosclerosis by including a specific cyclic amine derivative having an excellent blood platelet coagulation inhibiting action or arteriosclerosis exacerbation suppressing action. SOLUTION: This medicine includes the cyclic amine derivative expressed by formula I (R is phenyl; R is 1 to 8C aliphatic acyl, benzoyl or the like; R is a substituted 3 to 7 membered saturated cyclic amine which is substituted with mercapto or a mercapto substituted with an 1 to 4C alkyl or the like) or its salt. 1-(α-Cyclopropylcarbonyl-2-fluorobenzyl)-4-mercaptopiperidine or the like is preferred as the compound of formula I. The compound of formula I is obtained by reacting a compound of formula II (R a is the same as R excluding that the hydroxyl group of the R is protected; R a partially differs from R as to its substituent) with a halogenating agent such as carbon tetrabromide or the like then reacting with a compound of the formula: M- S-COR (M is an alkali metal; R is 1 to 4C alkyl).
Abstract:
NEW MATERIAL:A compound of formula I [Ar , Ar are phenyl or pyridyl which can be substituted; X is 1-10C alkylene, group of formula II (n is 1-8); Y is O, CONH; Z is halogen, alkyl, phenyl substituted with OH, CN, etc., group of formula III or IV (R is H, alkyl, OH, etc.; R is carboxyl, CN, phenyl, tetrazolyl, etc.; R is H, alkyl; R is H, alkoxycarbonyl)] and a salt thereof. EXAMPLE:1-[3-(4-Acetyl-3-hydroxy-2-n-propylphenoxy)propyl]-[(4-chlorop henyl-2- pyridylmethoxy]piperidine.fumaric acid salt. USE:A medicine having anti-histamine activity and anti-leukotriene activity. PREPARATION:For example, a compound of formula V is reacted with a compound of formula W-X-Y-Z (W is Cl, Br, methanesulfonyloxy) to obtain the compound of formula I.